Anchored by Centre for Cellular and Molecular Platforms (C-CAMP) on behalf of Bangalore Life Sciences Cluster and supported by Rockefeller Foundation, Indigenization of Diagnostics program or CCAMP-InDx in conjunction with National Biomedical Resources Consortium (N-BRIC), has enabled mass-scale availability of indigenously developed, ICMR/DCGI-approved COVID-19 diagnostic kits for Govt and private diagnostic labs facing any shortfall due to the current Tsunami of cases across India.

These kits are now directly accessible through the CCAMP-InDx deployed Marketplace platform designed pro-bono by TCS, that aims to connect kit buyers immediately with manufacturers.

The CCAMP-InDx Marketplace (web portal developed and supported by TCS) is up and running and companies that are on the portal can register their products, create "wants" and negotiate with suppliers. At this point in time 200+ products are registered on the portal. CCAMP now invites individual diagnostic labs, diagnostic lab chains, hospitals or pharma companies to join the portal.

As the country reels under this vicious Second Wave, CCAMP-InDx and N-BRIC can lead the fight back with resources for a vastly improved availability of diagnostic kits and enhanced connectivity between public healthcare system and Indian kit developers. The Indx-Market Place is now open for immediate business.

Both gold standard RT-PCR and antigen/antibody for serological surveys are available under these programs while the Marketplace is now open for access by all potential kit buyers.